Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy

Cell

Volumn 136, Issue 3, 2009, Pages 521-534

  Nicklin, Paul ^a   Bergman, Philip ^a   Zhang, Bailin ^a   Triantafellow, Ellen ^a   Wang, Henry ^a   Nyfeler, Beat ^a   Yang, Haidi ^a   Hild, Marc ^a   Kung, Charles ^a   Wilson, Christopher ^a   Myer, Vic E ^a   MacKeigan, Jeffrey P ^a   Porter, Jeffrey A ^a   Wang, Y Karen ^a   Cantley, Lewis C ^b   Finan, Peter M ^a   Murphy, Leon O ^a  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

CELLBIO; PROTEINS; SIGNALING

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER 5; GLUTAMINE; LEUCINE; MAMMALIAN TARGET OF RAPAMYCIN;

AMINO ACID TRANSPORT; ARTICLE; AUTOPHAGY; CELL GROWTH; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION;

MAMMALIA;

EID: 59049087460     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2008.11.044     Document Type: Article

References (59)

1. Anjum R., and Blenis J. The RSK family of kinases: emerging roles in cellular signalling. Nat. Rev. Mol. Cell Biol. 9 (2008) 747-758
2. Arsham A.M., and Neufeld T.P. Thinking globally and acting locally with TOR. Curr. Opin. Cell Biol. 18 (2006) 589-597
3. Blommaart E.F., Luiken J.J., Blommaart P.J., van Woerkom G.M., and Meijer A.J. Phosphorylation of ribosomal protein S6 is inhibitory for autophagy in isolated rat hepatocytes. J. Biol. Chem. 270 (1995) 2320-2326
4. Boado R.J., Li J.Y., Nagaya M., Zhang C., and Pardridge W.M. Selective expression of the large neutral amino acid transporter at the blood-brain barrier. Proc. Natl. Acad. Sci. USA 96 (1999) 12079-12084
5. Bodine S.C., Stitt T.N., Gonzalez M., Kline W.O., Stover G.L., Bauerlein R., Zlotchenko E., Scrimgeour A., Lawrence J.C., Glass D.J., et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat. Cell Biol. 3 (2001) 1014-1019
6. Cardenas M.E., Cutler N.S., Lorenz M.C., Di Como C.J., and Heitman J. The TOR signaling cascade regulates gene expression in response to nutrients. Genes Dev. 13 (1999) 3271-3279
7. Christa L., Simon M.T., Flinois J.P., Gebhardt R., Brechot C., and Lasserre C. Overexpression of glutamine synthetase in human primary liver cancer. Gastroenterology 106 (1994) 1312-1320
8. Colombani J., Raisin S., Pantalacci S., Radimerski T., Montagne J., and Leopold P. A nutrient sensor mechanism controls Drosophila growth. Cell 114 (2003) 739-749
9. Crespo J.L., and Hall M.N. Elucidating TOR signaling and rapamycin action: lessons from Saccharomyces cerevisiae. Microbiol. Mol. Biol. Rev. 66 (2002) 579-591
10. Crino P.B., Nathanson K.L., and Henske E.P. The tuberous sclerosis complex. N. Engl. J. Med. 355 (2006) 1345-1356
11. Dann S.G., and Thomas G. The amino acid sensitive TOR pathway from yeast to mammals. FEBS Lett. 580 (2006) 2821-2829
12. DeBerardinis R.J., Mancuso A., Daikhin E., Nissim I., Yudkoff M., Wehrli S., and Thompson C.B. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc. Natl. Acad. Sci. USA 104 (2007) 19345-19350
13. Dechelotte P., Darmaun D., Rongier M., Hecketsweiler B., Rigal O., and Desjeux J.F. Absorption and metabolic effects of enterally administered glutamine in humans. Am. J. Physiol. 260 (1991) G677-G682
14. Eagle H., Oyama V.I., Levy M., Horton C.L., and Fleischman R. The growth response of mammalian cells in tissue culture to L-glutamine and L-glutamic acid. J. Biol. Chem. 218 (1956) 607-616
15. Edinger A.L., and Thompson C.B. Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. Mol. Biol. Cell 13 (2002) 2276-2288
16. Esslinger C.S., Cybulski K.A., and Rhoderick J.F. Ngamma-aryl glutamine analogues as probes of the ASCT2 neutral amino acid transporter binding site. Bioorg. Med. Chem. 13 (2005) 1111-1118
17. Fingar D.C., Salama S., Tsou C., Harlow E., and Blenis J. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev. 16 (2002) 1472-1487
18. Fuchs B.C., and Bode B.P. Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime?. Semin. Cancer Biol. 15 (2005) 254-266
19. Fuchs B.C., and Bode B.P. Stressing out over survival: glutamine as an apoptotic modulator. J. Surg. Res. 131 (2006) 26-40
20. Gaugitsch H.W., Prieschl E.E., Kalthoff F., Huber N.E., and Baumruker T. A novel transiently expressed, integral membrane protein linked to cell activation. Molecular cloning via the rapid degradation signal AUUUA. J. Biol. Chem. 267 (1992) 11267-11273
21. Gebhardt R., and Williams G.M. Glutamine synthetase and hepatocarcinogenesis. Carcinogenesis 16 (1995) 1673-1681
22. Gingras A.C., Raught B., and Sonenberg N. mTOR signaling to translation. Curr. Top. Microbiol. Immunol. 279 (2004) 169-197
23. Hara K., Yonezawa K., Weng Q.P., Kozlowski M.T., Belham C., and Avruch J. Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. J. Biol. Chem. 273 (1998) 14484-14494
24. Hardwick J.S., Kuruvilla F.G., Tong J.K., Shamji A.F., and Schreiber S.L. Rapamycin-modulated transcription defines the subset of nutrient-sensitive signaling pathways directly controlled by the Tor proteins. Proc. Natl. Acad. Sci. USA 96 (1999) 14866-14870
25. Holecek M. Relation between glutamine, branched-chain amino acids, and protein metabolism. Nutrition 18 (2002) 130-133
26. Holz M.K., Ballif B.A., Gygi S.P., and Blenis J. mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. Cell 123 (2005) 569-580
27. Huang J., and Manning B.D. The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Biochem. J. 412 (2008) 179-190
28. Jacinto E., Loewith R., Schmidt A., Lin S., Ruegg M.A., Hall A., and Hall M.N. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat. Cell Biol. 6 (2004) 1122-1128
29. Jacinto E., and Lorberg A. TOR regulation of AGC kinases in yeast and mammals. Biochem. J. 410 (2008) 19-37
30. Kanai Y., Segawa H., Miyamoto K., Uchino H., Takeda E., and Endou H. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J. Biol. Chem. 273 (1998) 23629-23632
31. Kim D.H., Sarbassov D.D., Ali S.M., King J.E., Latek R.R., Erdjument-Bromage H., Tempst P., and Sabatini D.M. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110 (2002) 163-175
32. Kim E., Goraksha-Hicks P., Li L., Neufeld T.P., and Guan K.L. Regulation of TORC1 by Rag GTPases in nutrient response. Nat. Cell Biol. 10 (2008) 935-945
33. Kimura S., Noda T., and Yoshimori T. Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy 3 (2007) 452-460
34. Kovacevic Z., and Morris H.P. The role of glutamine in the oxidative metabolism of malignant cells. Cancer Res. 32 (1972) 326-333
35. Liu X.M., Reyna S.V., Ensenat D., Peyton K.J., Wang H., Schafer A.I., and Durante W. Platelet-derived growth factor stimulates LAT1 gene expression in vascular smooth muscle: role in cell growth. FASEB J. 18 (2004) 768-770
36. Ma X.M., Yoon S.O., Richardson C.J., Julich K., and Blenis J. SKAR links pre-mRNA splicing to mTOR/S6K1-mediated enhanced translation efficiency of spliced mRNAs. Cell 133 (2008) 303-313
37. Martin J.F., Hersperger E., Simcox A., and Shearn A. minidiscs encodes a putative amino acid transporter subunit required non-autonomously for imaginal cell proliferation. Mech. Dev. 92 (2000) 155-167
38. Martin K.A., and Blenis J. Coordinate regulation of translation by the PI 3-kinase and mTOR pathways. Adv. Cancer Res. 86 (2002) 1-39
39. Mastroberardino L., Spindler B., Pfeiffer R., Skelly P.J., Loffing J., Shoemaker C.B., and Verrey F. Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family. Nature 395 (1998) 288-291
40. McGivan J.D., and Bungard C.I. The transport of glutamine into mammalian cells. Front. Biosci. 12 (2007) 874-882
41. Meier C., Ristic Z., Klauser S., and Verrey F. Activation of system L heterodimeric amino acid exchangers by intracellular substrates. EMBO J. 21 (2002) 580-589
42. Mittendorfer B., Volpi E., and Wolfe R.R. Whole body and skeletal muscle glutamine metabolism in healthy subjects. Am. J. Physiol. Endocrinol. Metab. 280 (2001) E323-E333
43. Mizushima N., Levine B., Cuervo A.M., and Klionsky D.J. Autophagy fights disease through cellular self-digestion. Nature 451 (2008) 1069-1075
44. Nii T., Segawa H., Taketani Y., Tani Y., Ohkido M., Kishida S., Ito M., Endou H., Kanai Y., Takeda E., et al. Molecular events involved in up-regulating human Na+-independent neutral amino acid transporter LAT1 during T-cell activation. Biochem. J. 358 (2001) 693-704
45. Ohanna M., Sobering A.K., Lapointe T., Lorenzo L., Praud C., Petroulakis E., Sonenberg N., Kelly P.A., Sotiropoulos A., and Pende M. Atrophy of S6K1(-/-) skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control. Nat. Cell Biol. 7 (2005) 286-294
46. Reitzer L.J., Wice B.M., and Kennell D. Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. J. Biol. Chem. 254 (1979) 2669-2676
47. Sancak Y., Peterson T.R., Shaul Y.D., Lindquist R.A., Thoreen C.C., Bar-Peled L., and Sabatini D.M. The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1. Science 320 (2008) 1496-1501
48. Sarbassov D.D., Ali S.M., Kim D.H., Guertin D.A., Latek R.R., Erdjument-Bromage H., Tempst P., and Sabatini D.M. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14 (2004) 1296-1302
49. Sarbassov D.D., Ali S.M., and Sabatini D.M. Growing roles for the mTOR pathway. Curr. Opin. Cell Biol. 17 (2005) 596-603
50. Segawa H., Fukasawa Y., Miyamoto K., Takeda E., Endou H., and Kanai Y. Identification and functional characterization of a Na+-independent neutral amino acid transporter with broad substrate selectivity. J. Biol. Chem. 274 (1999) 19745-19751
51. Shaw R.J., and Cantley L.C. Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 441 (2006) 424-430
52. Smith E.M., Finn S.G., Tee A.R., Browne G.J., and Proud C.G. The tuberous sclerosis protein TSC2 is not required for the regulation of the mammalian target of rapamycin by amino acids and certain cellular stresses. J. Biol. Chem. 280 (2005) 18717-18727
53. Takeshige K., Baba M., Tsuboi S., Noda T., and Ohsumi Y. Autophagy in yeast demonstrated with proteinase-deficient mutants and conditions for its induction. J. Cell Biol. 119 (1992) 301-311
54. Utsunomiya-Tate N., Endou H., and Kanai Y. Cloning and functional characterization of a system ASC-like Na+-dependent neutral amino acid transporter. J. Biol. Chem. 271 (1996) 14883-14890
55. Verrey F. System L: heteromeric exchangers of large, neutral amino acids involved in directional transport. Pflugers Arch. 445 (2003) 529-533
56. Wang X., Campbell L.E., Miller C.M., and Proud C.G. Amino acid availability regulates p70 S6 kinase and multiple translation factors. Biochem. J. 334 (1998) 261-267
57. Wolf D.A., Wang S., Panzica M.A., Bassily N.H., and Thompson N.L. Expression of a highly conserved oncofetal gene, TA1/E16, in human colon carcinoma and other primary cancers: homology to Schistosoma mansoni amino acid permease and Caenorhabditis elegans gene products. Cancer Res. 56 (1996) 5012-5022
58. Wullschleger S., Loewith R., and Hall M.N. TOR signaling in growth and metabolism. Cell 124 (2006) 471-484
59. Yanagida O., Kanai Y., Chairoungdua A., Kim D.K., Segawa H., Nii T., Cha S.H., Matsuo H., Fukushima J., Fukasawa Y., et al. Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochim. Biophys. Acta 1514 (2001) 291-302